admin
- Alzheimer's & Dementia Research
- March 4, 2026
- 29 views
Lord Cameron Concludes Transformative Presidency at Alzheimer’s Research UK, Transitions to Enduring Patronage
Following his recent appointment as Secretary of State for Foreign, Commonwealth and Development Affairs, Lord David Cameron has formally stepped down from his role as President of Alzheimer’s Research UK,…
- Alzheimer's & Dementia Research
- March 3, 2026
- 27 views
Groundbreaking Study Links Wide Range of Modifiable Factors to Young-Onset Dementia Risk
A comprehensive new study, conducted by researchers in the UK and the Netherlands, has unveiled a significant association between a broad spectrum of health and lifestyle factors and an elevated…
- Alzheimer's & Dementia Research
- March 2, 2026
- 26 views
A £500,000 Grant Fuels Groundbreaking Research into Alzheimer’s Disease at University of Dundee, Targeting Microglial Transformation
A substantial grant of £500,000 has been jointly awarded to Dr. Amy Lloyd at the University of Dundee, marking a significant advancement in the global effort to combat Alzheimer’s disease.…
- Alzheimer's & Dementia Research
- March 2, 2026
- 26 views
Commercial Blood Test Matches Lumbar Puncture Accuracy for Alzheimer’s Detection, Offering a Glimmer of Hope for Early Diagnosis
A groundbreaking study led by researchers in Sweden has revealed that a readily available commercial blood test can detect Alzheimer’s disease with an accuracy comparable to that of standard lumbar…
- Alzheimer's & Dementia Research
- March 1, 2026
- 27 views
Government Announces £49.9 Million Boost to Expand UK Dementia Research Sites, Accelerating Search for Cure
The UK government today unveiled a significant financial commitment, allocating £49.9 million towards the expansion of dementia research sites across the nation. This pivotal investment aims to dramatically increase opportunities…
- Alzheimer's & Dementia Research
- March 1, 2026
- 28 views
Decades-Old Medical Treatment Linked to Five Cases of Transmitted Alzheimer’s Disease, New Study Reveals
Groundbreaking research published today in the prestigious journal Nature Medicine has brought to light an unprecedented connection between a medical treatment administered decades ago and the subsequent development of Alzheimer’s…
- Alzheimer's & Dementia Research
- February 28, 2026
- 28 views
Biogen Halts Aducanumab Development and Marketing, Signaling a Pivotal Shift in Alzheimer’s Treatment Strategy
Pharmaceutical giant Biogen announced this week its decision to discontinue the development and marketing of aducanumab, commercially known as Aduhelm, an Alzheimer’s drug that garnered both groundbreaking attention and significant…
- Alzheimer's & Dementia Research
- February 28, 2026
- 30 views
Alzheimer’s Research UK Bolsters Leadership with Four Eminent Trustees to Accelerate "Towards A Cure" Strategy
Alzheimer’s Research UK, the nation’s leading dementia research charity, officially announced on Wednesday, February 7, 2024, the appointment of four distinguished individuals to its Board of Trustees. These new Trustees,…
- Alzheimer's & Dementia Research
- February 27, 2026
- 35 views
Erectile Dysfunction Drugs Linked to Reduced Alzheimer’s Risk in Landmark UCL Study
New research from University College London (UCL), published in the online issue of the medical journal Neurology, has revealed a compelling association between the use of drugs designed to treat…
- Alzheimer's & Dementia Research
- February 27, 2026
- 69 views
New Alzheimer’s Treatments Lecanemab and Donanemab: A Turning Point Amidst NHS Readiness Concerns
The landscape of Alzheimer’s disease treatment is on the cusp of a transformative shift, heralded by the potential arrival of two pioneering drugs, lecanemab and donanemab. Recent BBC Panorama episode,…
